Cancer in Patients With Gabapentin (GPRD)

Clinical trial NCT01236053 · COMPLETED

Trial details

NCT number: NCT01236053
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pain, Neuropathic Epilepsy Renal Pelvis Cancer Pancreatic Cancer Breast Cancer Nervous System Cancer Chronic Pancreatitis Stomach Cancer Renal Cell Carcinoma Diabetes Bladder Cancer Bone and Joint Cancer

Start date: 2010-06-01
Primary completion: 2010-09-01
Enrollment: 2323608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.